.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
AstraZeneca
US Department of Justice
Harvard Business School
Johnson and Johnson
Moodys
Federal Trade Commission
Cipla
Farmers Insurance
Boehringer Ingelheim

Generated: February 23, 2018

DrugPatentWatch Database Preview

Patents Expiring in November 2029

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Kaleo IncEVZIOnaloxone hydrochlorideSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS209862-001Oct 19, 2016RXYesYes➤ Sign Up➤ Sign UpY
Kaleo IncEVZIOnaloxone hydrochlorideSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS205787-001Apr 3, 2014DISCNYesNo➤ Sign Up➤ Sign UpY
Kaleo IncAUVI-QepinephrineSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo➤ Sign Up➤ Sign UpY
Kaleo IncAUVI-QepinephrineSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS201739-002Aug 10, 2012BXRXYesYes➤ Sign Up➤ Sign UpY
Kaleo IncAUVI-QepinephrineSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS201739-003Nov 17, 2017RXYesNo➤ Sign Up➤ Sign UpY
Allergan Sales LlcGELNIQUEoxybutynin chlorideGEL;TRANSDERMAL022204-001Jan 27, 2009RXYesYes➤ Sign Up➤ Sign UpTREATMENT OF OVERACTIVE BLADDER BY APPLICATION OF OXYBUTYNIN CHLORIDE GEL TO SKIN
Pf Prism CvXALKORIcrizotinibCAPSULE;ORAL202570-002Aug 26, 2011RXYesYes➤ Sign Up➤ Sign UpYY
Pf Prism CvXALKORIcrizotinibCAPSULE;ORAL202570-001Aug 26, 2011RXYesNo➤ Sign Up➤ Sign UpYY
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-001Aug 13, 2009RXYesNo➤ Sign Up➤ Sign UpTREATMENT OF MODERATE TO SEVERE CHRONIC PAIN BY ADMINISTERING AN INTACT COMPOSITION AS CLAIMED
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-006Aug 13, 2009RXYesNo➤ Sign Up➤ Sign UpTREATMENT OF MODERATE TO SEVERE CHRONIC PAIN BY ADMINISTERING AN INTACT COMPOSITION AS CLAIMED
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Daiichi Sankyo
McKinsey
Healthtrust
Baxter
Fish and Richardson
Merck
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot